Vilpower Tablets contain Vildagliptin 50 mg. Vildagliptin is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor used to improve glycaemic control in adults with Type 2 Diabetes Mellitus.

Vilpower Tablets contain Vildagliptin, a selective DPP-4 inhibitor that enhances endogenous incretin hormone activity, leading to glucose-dependent insulin secretion and suppression of glucagon release. It effectively controls both fasting and postprandial blood glucose levels while maintaining a low risk of hypoglycaemia when used appropriately. The tablet can be administered with or without food, providing flexibility and convenience for patients requiring long-term diabetes management.

Vilpower Tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with Type 2 Diabetes Mellitus.

Vilpower Tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with Type 2 Diabetes Mellitus.

The recommended dose is 50 mg twice daily, with one tablet taken in the morning and one tablet in the evening. Vilpower Tablets may be administered with or without food, or as directed by the treating physician.

Vilpower Tablets are contraindicated in patients with known hypersensitivity to Vildagliptin or any component of the formulation.